Agenda for Meeting 18: Aug. 20, 2014 in Washington, D.C.

Hamilton Crowne Plaza Hotel
1001 14th Street, NW
Washington, DC 20005

Wednesday, August 20

9:00 – 9:15 a.m.  Welcome and Opening Remarks

Amy Gutmann, Ph.D.
Commission Chair

James Wagner, Ph.D.
Commission Vice Chair

9:15 – 10:30 a.m. Session 1: Ethical Considerations in Cognitive Enhancement

Peter Reiner, V.M.D., Ph.D.              
Professor, National Core for Neuroethics
Kinsmen Laboratory of Neurological Research and Brain Research Centre, Department of Psychiatry
University of British Columbia

Rear Admiral Peter J. Delany, Ph.D., LCSW-C 
Director, Center for Behavioral Health Statistics and Quality
Substance Abuse and Mental Health Services Administration

Adrian Raine, Ph.D.    
Richard Perry University Professor of Criminology, Psychiatry, and Psychology
University of Pennsylvania

Nick Bostrom, Ph.D.   
Professor, Faculty of Philosophy
Director, Future of Humanity Institute
Director, Programme on the Impacts of Future Technology
University of Oxford

10:30 – 10:45 a.m. Break

10:45 a.m. – 12:00 p.m.  Session 2: Direct-to-Consumer Neurotechnology

John Reppas, M.D., Ph.D.   
Director of Public Policy
Neurotechnology Industry Organization

Carlos Peña, Ph.D., M.S.  
Director, Division of Neurological and Physical Medicine Devices
Office of Device Evaluation
Center for Devices and Radiological Health
U.S. Food and Drug Administration

Freddie Ann Hoffman, M.D.   
Chief Executive Officer and Founding Member
HeteroGeneity LLC
Former Deputy Director, Medicine Staff
Office of the Commissioner
U.S. Food and Drug Administration

Deven McGraw, J.D., M.P.H., LL.M.  
Partner, Manatt, Phelps & Phillips, LLP
Former Director, Health Privacy Project
Center for Democracy and Technology

12:00 – 1:15 p.m.  Lunch Break

1:15 – 2:15 p.m. Session 3: Neuroscience Research – Clinical Innovation and Applications

Steven L. Small, Ph.D., M.D.  
Stanley van den Noort Professor and Chair,
Department of Neurology
Professor of Neurobiology and Behavior
Professor of Cognitive Sciences
Director, Neuroscience Imaging Center
University of California, Irvine
Professor Emeritus of Neurology,
The University of Chicago

Paul J. Ford, Ph.D.    
Program Director, NeuroEthics Program
Education Director, Department of Bioethics
Cleveland Clinic
Associate Professor, Division of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Helen Mayberg, M.D.   
Professor of Psychiatry, Neurology, and Radiology
Dorothy C. Fuqua Chair, Psychiatric Neuroimaging and Therapeutics
Emory University School of Medicine

2:15 – 3:00 p.m.  Session 4: Neuroscience Research and Diminished Capacity

Jerry Menikoff, M.D., J.D.   
Director, Office for Human Research Protections
U.S. Department of Health and Human Services

Paul S. Appelbaum, M.D.  
Elizabeth K. Dollard Professor of Psychiatry, Medicine & Law
Director, Division of Psychiatry, Law, and Ethics
Director, Center for Research on Ethical, Legal & Social Implications of Psychiatric, Neurologic & Behavioral Genetics
Department of Psychiatry
Columbia University

3:00 – 3:15 p.m.  Break

3:15 – 4:45 p.m. Session 5: Roundtable Discussion

4:45 – 5:00 p.m. Concluding Remarks

Amy Gutmann, Ph.D.
James Wagner, Ph.D.


This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.